specialty clinics
Scope
Date
~
-
Bio & Pharma
KT, Hanmi-invested therapeutics maker Digital Pharm launched
Digital Pharm, jointly invested in by KT Corp. and Hanmi Pharmaceutical Co., held an official inauguration ceremony last week, the company announced...
Jun 20, 2022 (Gmt+09:00)
-
Bio & Pharma
Samsung Bioepis’ SB12 shows same clinical effects as Alexion’s Soliris
Samsung Bioepis Co., a biopharmaceutical unit of Samsung Group, said its SB12, a proposed biosimilar to Alexion Pharmaceuticals Inc.’s rare bl...
Jun 14, 2022 (Gmt+09:00)
language -
Pre-IPOs
Lemon Healthcare aims for IPO and triple jump in revenue
Imagine making a doctor’s appointment with a click of a button on a smartphone app. Once at the clinic or hospital, the app will guide the use...
Jun 02, 2022 (Gmt+09:00)
-
Metaverse
Biotech firm EDGC embarks on metaverse journey
EONE-DIAGNOMICS Genome Center Co. ( EDGC ) announced this week it would participate in AI Human Metaverse Project consortium – along with seven ...
Jan 05, 2022 (Gmt+09:00)
-
Pharmeceuticals
Kolon resumes Invossa phase 3 clinical trials in US
Kolon TissueGene Inc., the cell therapies unit of South Korean pharmaceutical company Kolon Life Science Inc., said on Dec. 28 it has resumed admi...
Dec 28, 2021 (Gmt+09:00)
-
Mergers & Acquisitions
Lotte Chemical seeks to acquire Japanese specialty chemical firms
Lotte Chemical Corp. is seeking to acquire major stakes in a few specialty chemical companies in Japan as the South Korean company aims to expand it...
Nov 22, 2021 (Gmt+09:00)
language -
Electronics
LG to expand medical equipment business with pain-relieving device
LG Electronics Inc. is expanding its business scope to the medical equipment sector with a plan to unveil a pain-relieving device in an effort to ga...
Nov 10, 2021 (Gmt+09:00)
language -
Korean startups
Specialty coffee brand Terarosa raises $60 mn from Unison Capital
The operator of Terarosa, known as the Blue Bottle Coffee of South Korea, has received around 70 billion won ($60 million) in funding from Unison Ca...
Nov 02, 2021 (Gmt+09:00)
-
COVID-19
Celltrion to enter clinical trials of new COVID-19 treatment
South Korean biosimilar maker Celltrion Inc. will launch the first-phase clinical trials of its new COVID-19 treatment candidate next month, followi...
Aug 05, 2021 (Gmt+09:00)
language -
COVID-19
Eyegene to kick off Korea’s first mRNA clinical trial
Eyegene Inc. will be South Korea’s first vaccine maker to conduct clinical tests of messenger ribonucleic acid (mRNA) COVID-19 vaccines. Ealie...
Jul 01, 2021 (Gmt+09:00)
-
Petrochemicals
S.Korean chem firms look to specialty chemicals to drive growth
South Korea-based Kumho Petrochemical Co. stunned the market last year with a positive earnings surprise in the third quarter of 2020. The company...
Jan 17, 2021 (Gmt+09:00)
language